Sciencast Management LP Takes $356,000 Position in Baxter International Inc. $BAX

Key Points

• Sciencast Management LP invested approximately $356,000 in Baxter International, acquiring 10,413 shares in the first quarter. This investment reflects growing institutional interest in the company.
• Baxter International's stock currently has a market cap of $12.37 billion and reported a loss of $0.01 in earnings per share compared to analysts' expectations.
• The company announced a quarterly dividend of $0.17 per share, with a dividend yield of 2.8%, though its current dividend payout ratio is significantly negative at -226.67%.

Sciencast Management LP acquired a new stake in Baxter International Inc. (NYSE:BAX - Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 10,413 shares of the medical instruments supplier's stock, valued at approximately $356,000.

Other institutional investors have also recently bought and sold shares of the company. Raiffeisen Bank International AG grew its stake in Baxter International by 24.9% in the 1st quarter. Raiffeisen Bank International AG now owns 95,668 shares of the medical instruments supplier's stock valued at $3,229,000 after purchasing an additional 19,081 shares during the period. New York State Common Retirement Fund grew its stake in Baxter International by 30.9% in the 1st quarter. New York State Common Retirement Fund now owns 623,403 shares of the medical instruments supplier's stock valued at $21,339,000 after purchasing an additional 147,155 shares during the period. Dodge & Cox grew its stake in Baxter International by 2.1% in the 1st quarter. Dodge & Cox now owns 51,458,925 shares of the medical instruments supplier's stock valued at $1,761,439,000 after purchasing an additional 1,081,631 shares during the period. GAMMA Investing LLC grew its stake in Baxter International by 248.3% in the 1st quarter. GAMMA Investing LLC now owns 11,326 shares of the medical instruments supplier's stock valued at $388,000 after purchasing an additional 8,074 shares during the period. Finally, SG Americas Securities LLC grew its stake in Baxter International by 352.6% in the 1st quarter. SG Americas Securities LLC now owns 74,094 shares of the medical instruments supplier's stock valued at $2,536,000 after purchasing an additional 57,723 shares during the period. Institutional investors own 90.19% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Stifel Nicolaus restated a "hold" rating and issued a $25.00 price objective (down from $36.00) on shares of Baxter International in a research note on Monday, August 4th. Wall Street Zen cut Baxter International from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. UBS Group lowered their price objective on Baxter International from $35.00 to $24.00 and set a "neutral" rating on the stock in a research note on Monday, August 4th. Barclays lowered their price objective on Baxter International from $41.00 to $36.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Finally, Wells Fargo & Company lowered their price objective on Baxter International from $33.00 to $24.00 and set an "equal weight" rating on the stock in a research note on Friday, August 1st. Three analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $30.11.

Baxter International Price Performance

Shares of Baxter International stock traded down $0.49 on Friday, reaching $24.00. The stock had a trading volume of 5,749,897 shares, compared to its average volume of 5,978,039. Baxter International Inc. has a 1 year low of $21.33 and a 1 year high of $40.49. The company has a market cap of $12.33 billion, a P/E ratio of -80.00, a price-to-earnings-growth ratio of 0.78 and a beta of 0.61. The company has a current ratio of 2.30, a quick ratio of 1.49 and a debt-to-equity ratio of 1.30. The business's 50 day moving average is $25.60 and its two-hundred day moving average is $29.31.

Baxter International (NYSE:BAX - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $0.59 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.60 by ($0.01). Baxter International had a positive return on equity of 16.96% and a negative net margin of 1.42%.The firm had revenue of $2.81 billion during the quarter, compared to analysts' expectations of $2.82 billion. During the same period in the previous year, the company posted $0.68 earnings per share. The company's quarterly revenue was up 4.3% compared to the same quarter last year. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. As a group, research analysts anticipate that Baxter International Inc. will post 2.48 EPS for the current year.

Baxter International Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, August 29th will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Friday, August 29th. Baxter International's dividend payout ratio (DPR) is -226.67%.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.